Lapatinib Completed Phase 2 Trials for Neoplasms, Brain / Spinal Cord Tumors Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 2 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT00826241 | Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma |